Hwail Pharm Co Ltd
KOSDAQ:061250
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hwail Pharm Co Ltd
KOSDAQ:061250
|
KR |
|
Molecular Partners AG
NASDAQ:MOLN
|
CH |
|
Telefonaktiebolaget LM Ericsson
NASDAQ:ERIC
|
SE |
|
A
|
Amarin Corporations PCL
SET:AMARIN
|
TH |
|
P
|
Platinum Group PCL
SET:PLAT
|
TH |
Intrinsic Value
Is Hwail Pharm Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Hwail Pharm Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Hwail Pharm Co Ltd looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Hwail Pharm Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Hwail Pharm Does
Hwail Pharm is a South Korean pharmaceutical company that makes and sells finished medicines and related health products. Its core business is turning drug formulas into packaged products that can be prescribed by doctors or sold through pharmacies and other healthcare channels. In plain terms, it sits on the manufacturing side of the drug supply chain, where quality, regulatory approval, and reliable production matter most.
- Headquarters
- Korea KR
- Employees
- 149
- IPO date
- Apr 18, 2002
Revenue & Expenses Breakdown
Hwail Pharm Co Ltd
Earnings Waterfall
Hwail Pharm Co Ltd
The intrinsic value for Hwail Pharm Co Ltd (061250) under the Base Case is hidden KRW.
Compared with the current market price of 6 300 KRW, the stock appears hidden.